NVTA US46185L1035

Report

Delayed Nyse - 09/22 04:10:00 pm
31.73	USD		-0.19%

09/09	VC DAILY : Digital Health Is Booming, but VC Doesn't See a Bubble Forming	DJ
09/07	INVITAE : Ciitizen Announcement Conference Call Presentation	PU
09/07	INVITAE : — Combination to bring together the power of genomic and clinical information within a new kind of patient data platform to improve healthcare decision making at personal and systemwide levels — (Form 8-K)	PU

Summary

Quotes 5-day view Delayed Quote.

Delayed Nyse

09/16/2021	09/17/2021	09/20/2021	09/21/2021	09/22/2021	Date
29.74(c)	31.54(c)	30.83(c)	31.79(c)	31.73	Last
2 272 846	5 211 131	2 824 313	4 167 127	1 868 079	Volume
+0.37%	+6.05%	-2.25%	+3.11%	-0.19%	Change

More quotes

Estimated financial data (e) (USD)

Sales 2021	484 M - -
Net income 2021	-530 M - -
Net Debt 2021	342 M - -
P/E ratio 2021	-12,5x
Yield 2021	-

Sales 2022	673 M - -
Net income 2022	-653 M - -
Net Debt 2022	378 M - -
P/E ratio 2022	-10,4x
Yield 2022	-

Capitalization	6 896 M 6 896 M -
EV / Sales 2021	14,9x
EV / Sales 2022	10,8x
Nbr of Employees	2 600
Free-Float	97,0%

More Financials

Company

Invitae Corporation is a medical genetics company. The Company is engaged in delivering genetic testing services that support a lifetime of patient care from inherited disease diagnoses, to family planning, to proactive health screening to personalized diagnosis, treatment and monitoring of cancer. These tests are delivered through a platform that serves patients, healthcare providers, biopharma companies and other...

Sector

Biotechnology & Medical Research

Calendar

11/08

Earnings Release

More about the company

Ratings of Invitae Corporation

Trading Rating :

Investor Rating :

ESG Refinitiv :

More Ratings

All news about INVITAE CORPORATION

09/09	VC DAILY : Digital Health Is Booming, but VC Doesn't See a Bubble Forming	DJ
09/07	INVITAE : Ciitizen Announcement Conference Call Presentation	PU
09/07	INVITAE : — Combination to bring together the power of genomic and clinical informati..	PU
09/07	INVITAE CORP : Unregistered Sale of Equity Securities, Regulation FD Disclosure, Other Eve..	AQ
09/07	INVITAE : to Acquire Consumer Health Tech Company Ciitizen in $325 Million Deal	MT
09/07	INVITAE : to Acquire Ciitizen to Strengthen its Patient-Consented Health Data Platform to ..	PR
09/07	Invitae Corporation entered into definitive agreement to acquire Ciitizen Corporation f..	CI
09/01	INVITAE : to Present at the Morgan Stanley 19th Annual Global Healthcare Conference	PR
08/19	INVITAE : Significant Insider Sales in Shares of Invitae (NVTA) Extends the Selling Trend ..	MT
08/18	INSIDER TRENDS : 90-Day Insider Selling Trend Extended at Invitae	MT
08/18	INSIDER TRENDS : Invitae Insider Extends 90-Day Selling Trend	MT
08/18	INSIDER TRENDS : Invitae Insider Sale Scaling Back 90-Day Buy Trend	MT
08/09	INVITAE : Management's Discussion and Analysis of Financial Condition and Results of Opera..	AQ
08/09	INVITAE : to Present at the UBS Genomics 2.0 and MedTech Innovations Summit	PR
08/09	Global markets live: Alibaba, Citigroup, Tyson Foods, Veoneer, Cisco...

More news

News in other languages on INVITAE CORPORATION

08/19	Une importante vente d'initiés sur les actions d'Invitae (NVTA) prolonge la tendance à ..
08/09	EN DIRECTO DESDE LOS MERCADOS : Sika, ByteDance, Renault, Logitech, PostNL, Aramco, Philip..
08/09	MADRID STOCK EXCHANGE : Resultados casi perfectos
08/09	STOCK MARKET PARIS : Des résultats presque parfaits
08/09	EN DIRECT DES MARCHES : EDF, Renault, Atos, Rémy Cointreau, Logitech, PostNL, Aramco, Phil..

More news

Analyst Recommendations on INVITAE CORPORATION

08/04	INVITAE : Benchmark Upgrades Invitae to Buy From Hold	MT
06/21	INVITAE : Wells Fargo Adjusts Invitae's Price Target to to $35 From $30, Keeps Equal-Weigh..	MT
06/15	INVITAE : Raymond James Initiates Coverage on Invitae With Outperform Rating, $37 Price Ta..	MT

More recommendations

Provided by Scoopnest.com

Analysis

SoftBank : Franklin invest $210 million in OneTrust at over $5 billion valuation